Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations Meeting Abstract
| Authors: | Abida, W.; Bryce, A. H.; Vogelzang, N. J.; Amato, R. J.; Percent, I.; Shapiro, J. D.; McDermott, R.; Hussain, A.; Patnaik, A.; Petrylak, D.; Ryan, C. J.; Stanton, T.; Zhang, J.; Simmons, A. D.; Despain, D.; Collins, M.; Golsorskhi, T.; Scher, H. I.; Chowdhury, S. |
| Abstract Title: | Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy284.002 |
| Language: | English |
| ACCESSION: | WOS:000459277301372 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy284.002 |
| Notes: | Meeting Abstract: 793PD -- Appears on page viii272 of the abstract book -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
